Whether you're still in the early planning phase or you have a candidate ready for clinical testing, we are here to help your organization achieve excellence in execution.
Accelovance specializes in:
Let us share with you our learnings and best practices for success, including ways to expedite timelines and reduce trial costs. Stop by Booth #71 at OCT New England 2017, or better yet, schedule a meeting with us!
Win An Apple Watch
An additional benefit of coming by our booth? We'll be raffling off a brand new Apple Watch! Come on by and say hello to be entered in the drawing.
Can't make it to Boston for Outsourcing in Clinical Trials New England this year? No worries, we realize you have a busy schedule. Reach out to us, and we're happy to provide more information about our CRO services and solutions for your upcoming clinical research program.
Accelovance is an award-winning, clinical development CRO focused on oncology and immunological vaccine programs across phase I-IV. The HERO Initiative by Accelovance is a specialized early phase oncology program providing emerging and established biotech and pharmaceutical companies an accelerated means of advancing their early phase cancer compounds through clinical testing. Learn more about our services: